These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Hydroxyquinoline derivatives and the nervous system]. Cohen D; Streifler M Harefuah; 1972 Oct; 83(7):274-5. PubMed ID: 4361085 [No Abstract] [Full Text] [Related]
5. [Notes on neuropathies appearing during treatments with clioquinol]. Schoeller JP Therapie; 1973; 28(2):401-4. PubMed ID: 4358277 [No Abstract] [Full Text] [Related]
6. [Bilateral optic atrophy in a one and one-half-year-old child possibly a result of administration of iodochlorhydroxyquinoline (Enterovioform)]. Drukker J; Lindenburg PA Ned Tijdschr Geneeskd; 1972 Sep; 116(36):1618-20. PubMed ID: 4262826 [No Abstract] [Full Text] [Related]
7. A case of optic atrophy possibly induced by quinoline in acrodermatitis enteropathica. Garcia-Perez A; Castro C; Franco A; Escribano R Br J Dermatol; 1974 Apr; 90(4):453-5. PubMed ID: 4274690 [No Abstract] [Full Text] [Related]
8. [Ocular side effects of chloroquine treatment of rheumatoid arthritis patients]. Glennås A; Brath HK; Bergaust B Tidsskr Nor Laegeforen; 1980 May; 100(13):902-3. PubMed ID: 7385132 [No Abstract] [Full Text] [Related]
10. [Severe myelopathy, peripheral neuropathy and optic neuritis appearing during treatment with chloroiodoquin (clioquinol)]. Castaiggne P; Rondot P; Lenoel Y; Ribadeau Dumas JL; Autret A Therapie; 1973; 28(2):393-400. PubMed ID: 4358276 [No Abstract] [Full Text] [Related]
11. Toxic damage to the optic nerve caused by iodochlorhydroxyquinoline (enterovioform). van Balen AT Ophthalmologica; 1971; 163(1):8-9. PubMed ID: 4257124 [No Abstract] [Full Text] [Related]
12. [Long-term chloroqine therapy of chronic rheumatic diseases]. Otto W; Tautenhahn B Munch Med Wochenschr; 1966 May; 108(18):999-1003. PubMed ID: 6014759 [No Abstract] [Full Text] [Related]
13. SMON as seen from Bombay. Wadia NH Acta Neurol Scand Suppl; 1984; 100():159-64. PubMed ID: 6091394 [TBL] [Abstract][Full Text] [Related]
14. [On ocular damage caused by chloroquine]. Rinaldi G; Coslovich E; Tuvo F Minerva Med; 1971 Feb; 62(16):766-9. PubMed ID: 5313741 [No Abstract] [Full Text] [Related]
15. Transient dysaesthesiae and persistent leucocytosis after clioquinol therapy. Terry SI Br Med J; 1971 Sep; 3(5777):745. PubMed ID: 4329043 [No Abstract] [Full Text] [Related]
16. A neurological evaluation of purported cases of SMON in Sweden. Gilland O Acta Neurol Scand Suppl; 1984; 100():165-9. PubMed ID: 6091395 [TBL] [Abstract][Full Text] [Related]
17. Clioquinol and neurological disease. Br Med J; 1971 May; 2(5757):291-2. PubMed ID: 4252528 [No Abstract] [Full Text] [Related]
18. The effectiveness of CI-433 versus entero-vioform in the control of diarrhoeal disease. Grant LS; Belle EA; Ramprashad C West Indian Med J; 1968 Mar; 17(1):31-2 passim. PubMed ID: 4242951 [No Abstract] [Full Text] [Related]
19. American Academy of Pediatrics Committee on Drugs: Clioquinol (iodochlorhydroxyquin, vioform) and iodoquinol (diiodohydroxyquin): blindness and neuropathy. Pediatrics; 1990 Nov; 86(5):797-8. PubMed ID: 2146587 [No Abstract] [Full Text] [Related]
20. [A case of myelo-optic neuropathy preceded by abdominal symptoms]. Massons Cirera J; Zunzunegui Costas J; Titus Alvareda F Med Clin (Barc); 1983 Jun; 80(20):894-5. PubMed ID: 6224988 [No Abstract] [Full Text] [Related] [Next] [New Search]